Esperion Therapeutics | Lucro Bruto Sobre Vendas





Lucro Bruto Sobre Vendas Alterar Data
AbbVie USD 10.47B 605M 2025-09
Alnylam Pharmaceuticals USD 1.05B 418.14M 2025-09
Amarin USD 22.21M 28.15M 2025-09
Amgen USD 6.48B 307M 2025-09
Biogen USD 1.65B 34.6M 2025-12
BioMarin Pharmaceutical USD 631.2M 39.27M 2025-09
Cipla INR 41.64B 6.31B 2025-12
CSL USD 1.75B 2.53B 2025-06
Cytokinetics USD 1.94M 64.83M 2025-09
Daiichi Sankyo JPY 439.83B 95.05B 2025-12
Eli Lilly USD 14.59B 1.48B 2025-09
Esperion Therapeutics USD -29.52M 32.4M 2024-09
Geron USD 46.18M 1.66M 2025-09
Grifols EUR 766.49M 39.74M 2024-12
Halozyme Therapeutics USD 281.77M 2.41M 2025-09
Heron Therapeutics USD 23.35M 1.6M 2024-09
Ionis Pharmaceuticals USD 155M 293M 2025-09
Merck USD 13.42B 431M 2025-09
Minerva Neurosciences -4.27M 26.79M 2024-12
Moderna USD 809M 791M 2025-09
Nektar Therapeutics USD 13.75M 650K 2024-06
Pfizer USD 3.54B 7.61B 2025-09
PTC Therapeutics USD 187.69M 24.3M 2025-09
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
Sarepta Therapeutics USD 247.9M 209.96M 2025-09
United Therapeutics USD 602.1M 108.9M 2025-09
Vanda Pharmaceuticals USD 50.6M 5.5M 2024-12


Esperion Therapeutics Lucro Bruto Sobre Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.